ORTHO GETS FIRST FDA OKAY FOR THERAPEUTIC MONOCLONAL: ORTHOCLONE OKT3 APPROVED FOR RENAL TRANSPLANTS, TARGET POPULATION OF 4,000 PER YEAR

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".